A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

NCT07465679 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction

Sponsor

Novartis Pharmaceuticals